Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug Administration Center for Devices and Radiological Health Questions?
horizonal rule
(photos of mammography devices)Skip Mammography NavigationMammography
Information for mammography facility personnel, inspectors, and consumers              
about the implementation of the Mammography Quality Standards Act of 1992 (MQSA)
(nagivation toolbar)
Home About Regulations Guidance Certification/Inspection Scorecard Reports Consumers Archives Contact Us
MQSA Facility Score Card graphic

See Related

*

Updated Trends in Mammography Dose and Image Quality

(Related Article: Dose and Image Quality in Mammography: Trends during the First Decade of MQSA)

David C. Spelic, Ph.D.
US Food and Drug Administration
Division of Mammography Quality and Radiation Programs
1350 Piccard Drive HFZ-240
Rockville, MD 20850
Phone: 301-594-3525
Email: dcs@cdrh.fda.gov
6/16/2006

Line graph.

This graphic displays average values for mean glandular dose and estimates of image quality in mammography for the period from the early 1970’s to 2005. Doses in mammography have consistently decreased with time, with the most substantial reductions in dose occurring from the early 1970’s to the early 1980’s. Image quality data is presented from the mid-1980’s to present, and shows consistent improvement with time.

The early studies of 1974 and 1976 reported substantial contributions from xeromammography and direct-film procedures. Even during the first year of MQSA inspections in 1995, there were a number of facilities still using xeromammography. Technological improvements such as efficient screen-film technologies, molybdenum target-based x-ray units for mammography, and improvement in film processing quality contributed to further reduction in dose during the eighties and into the nineties. Dose and image quality trends have leveled off in recent years as the technical aspects of mammography became optimized. For further discussion on trends in dose and image quality in mammography refer to the article posted on the FDA’s website.

Average values for mean glandular dose are either reported by, or derived from data reported by the following sources:

1974

Bicehouse HJ. Survey of Mammographic Exposure Levels and Techniques Used in Eastern Pennsylvania. 7th Annual National Conference on Radiation Control, 1975. DHEW Publication (FDA) 76-8026.

1976

Butler PF, Jensen JE. Breast Exposure: Nationwide Trends; A Mammographic Quality Assurance Program- Results to Date. Radiologic Technology 50(3), 1978; pp 251-257.

1980

Breast Exposure: Nationwide Trends. In: Internal project progress report. Rockville MD: Bureau of Radiological Health, US Department of Health and Human Services, Food and Drug Administration, 1981.

1985, 1988, 1992

Conway BJ, Suleiman OH, Rueter FG, Antonsen RG, Slayton RJ. National Survey of Mammographic Facilities in 1985, 1988, and 1992. Radiology 1994; 191: 323-330.

1995 to present

Mammography Quality Standards Act (MQSA) inspection findings.

Image Quality scores are reported from the following sources:

NOTE: All image quality scores are reported without artifact subtraction.

1985

RMI 152 phantom with 'C' insert; 1985 Nationwide Evaluation of X-ray Trends (NEXT) survey data.

1988

RMI 156 phantom with 'C' insert; 1988 NEXT survey data.

1992

RMI 156 phantom with 'D' insert; 1992 NEXT survey data.

1995 to present

Mammography Quality Standards Act (MQSA) inspection findings

Back to Articles

Back to Mammography Home Page

Updated June 16, 2006

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH